Contents

5 Diphtheria

References

  1. Vitke C, Wharton M. 1998. Diphtheria in the former Soviet Union: re emergence of a pandemic disease. Emerging Infectious Diseases 4(4). URL: wwwnc.cdc.gov/eid/article/4/4/98-0404.htm (accessed 29 September 2013).
  2. American Academy of Pediatrics. 2012. Diphtheria. In: Pickering LK, Baker CJ, Kimberlin DW, et al (eds). Red Book: 2012 report of the Committee on Infectious Diseases (29th edition). Elk Grove Village, IL: American Academy of Pediatrics.
  3. Tiwari TSP, Wharton M. 2013. Diphtheria toxoid. In: Plotkin SA, Orenstein WA, Offit PA (eds). Vaccines (6th edition): Elsevier Saunders.
  4. Rasmussen I, Wallace S, Mengshoel A, et al. 2011. Diphtheria outbreak in Norway: lessons learned. Scandinavian Journal of Infectious Diseases 43: 986–9.
  5. Fredlund H, Norén T, Lepp T, et al. 2011. A case of diphtheria in Sweden, October 2011. Eurosurveillance 16(50). URL: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20038 (accessed 14 January 2013).
  6. Lindhusen-Lindhé E, Dotevall L, Berglund M. 2012. Imported laryngeal and cutaneous diphtheria in tourists returning from western Africa to Sweden, March. Eurosurveillance 17(23). URL: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20189 (accessed 14 January 2013).
  7. Centers for Disease Control and Prevention. 2012. Diphtheria. In: Atkinson W, Hamborsky J, Wolfe S, et al (eds). Epidemiology and Prevention of Vaccine-Preventable Diseases (12th edition). Washington DC: Public Health Foundation.
  8. Sears A, McLean M, Hingston D, et al. 2012. Cases of cutaneous diphtheria in New Zealand: implications for surveillance and management. New Zealand Medical Journal 125(1350): 64–71.
  9. Baker M, Taylor P, Wilson E, et al. 1998. A case of diphtheria in Auckland: implications for disease control. New Zealand Public Health Report 5(10): 73–6.
  10. Weir R, Jennings L, Young S, et al. 2009. National Serosurvey of Vaccine Preventable Diseases. URL: www.health.govt.nz/system/files/documents/publications/national-serosurvey-of-vaccine-preventable-diseases-may09.pdf
  11. Fine PEM. 1993. Herd immunity: history, theory, practice. Epidemiologic Reviews 15(2): 265–302.
  12. Smith JWG. 1969. Diphtheria and tetanus toxoids. British Medical Bulletin 25(2): 177–82.
  13. Ad-hoc Working Group. 1978. Susceptibility to diphtheria. The Lancet 311(8061): 428–30.
  14. World Health Organization. 2009. Module 2: Diphtheria – update 2009. The Immunological Basis for Immunization Series. URL: www.who.int/immunization/documents/immunological_basis_series/en/
  15. Bowie C. 1996. Tetanus toxoid for adults – too much of a good thing. The Lancet 348(9036): 1185–6.
  16. Stark K, Barg J, Molz B, et al. 1997. Immunity against diphtheria in blood donors in East and West Berlin. The Lancet 350(9082): 932.
  17. McIntyre PB, Burgess MA, Egan A, et al. 2009. Booster vaccination of adults with reduced-antigen-content diphtheria, tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination. Vaccine 27(7): 1062–6.
  18. Ministry of Health. 2012. National Guidelines for Vaccine Storage and Distribution. URL: www.health.govt.nz/publication/national-guidelines-vaccine-storage-and-distribution-2012
  19. Beytout J, Launay O, Guiso N, et al. 2009. Safety of Tdap-IPV given 1 month after Td-IPV booster in healthy young adults: a placebo controlled trial. Human Vaccines and Immunotherapeutics 5(5): 315–21.
  20. Talbot EA, Brown KH, Kirkland KB, et al. 2010. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of health care personnel during a respiratory illness outbreak. Vaccine 28(50): 8001–7.
  21. Centers for Disease Control and Prevention. 2011. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. Morbidity and Mortality Weekly Report 60(1). URL: www.cdc.gov/mmwr/pdf/wk/mm6001.pdf (accessed 21 October 2013).
  22. McCormack P. 2012. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix): a review of its properties and use as a single-dose booster immunization. Drugs 72(13): 1765–91.
  23. Stratton KR, Howe CJ, Johnston RB. 1994. Adverse events associated with childhood vaccines other than pertussis and rubella. Journal of the American Medical Association 271(20): 1602–5.
  24. Ministry of Health. 2012. Communicable Disease Control Manual 2012. URL: www.health.govt.nz/publication/communicable-disease-control-manual-2012
  25. Heymann DL (ed). 2008. Control of Communicable Diseases Manual (19th edition). Washington DC: American Public Health Association.